Safety, Tolerability and Pharmacokinetics of Multiple Doses of ZGN-433 in Obese Female Volunteers
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess whether multiple doses of ZGN-433 is safe and well
tolerated in obese female subjects. The study will also provide information on how much
ZGN-433 gets into the blood, how long does it stay in the body, and how it affects other
biological markers.